A vitamin as neuromodulator: Ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission
References (385)
- et al.
Oxygen free radicals and Parkinson's disease
Free Rad. Biol. Med.
(1991) In vivo electrochemical measurements in the CNS
Prog. Neurobiol.
(1990)- et al.
The functional anatomy of basal ganglia disorders
Trends Neurosci.
(1989) - et al.
Functional architecture of basal ganglia circuits: neural substrates of parallel processing
Trends Neurosci.
(1990) - et al.
Differential effects of ascorbate and EDTA on high-affinity binding of 3H-apomorphine and 3H-ADTN to calf caudate membranes
Neuropharmacology
(1982) Dopamine receptors in rat brain regions—Optimal conditions for 3H-agonist binding, pH dependency and lack of inhibition by ascorbic acid
Biochem. Pharmac.
(1982)- et al.
Corticostriatal and thalamic regulation of amphetamine-induced ascorbate release in the neostriatum
Pharmac. Biochem. Behav.
(1990) - et al.
Regional distribution of ascorbate and 3,4-dihydroxyphenylacetic acid (DOPAC) in rat neostriatum
Brain Res.
(1991) - et al.
The antioxidant role of vitamin C
Adv. Free Rad. Biol. Med.
(1986) The role of dopamine in locomotor activity and learning
Brain Res. Rev.
(1983)
On a possible mechanism of action of ascorbic acid: formation of ionic bonds with biological molecules
Biochem. biophys. Res. Commun.
(1981)
Calcium-independent release of amino acid neurotransmitters—fact or artifact
Prog. Neurobiol.
(1992)
Neuroleptics increase striatal catecholamine metabolites but not ascorbic acid in dialyzed perfusate
Brain Res.
(1984)
Rapid changes in striatal ascorbate in response to tail-pinch monitored by constant potential voltammetry
Neuroscience
(1989)
Intracerebral injection of ascorbate oxidase-effect on in vivo electrochemical recordings
Brain Res.
(1982)
Urinary oxalate and vitamin C supplements
The Lancet
(1973)
The pecking order of free radicals and antioxidants—lipid peroxidation, alpha-tocopherol, and ascorbate
Arch. Biochem. Biophys.
(1993)
The pharmacological profile of glutamate-evoked ascorbic acid efflux measured by in vivo electrochemistry
Brain Res.
(1991)
Antioxidants prevent the interaction of 3,4-dydroxyphenylacetic acid at the dopamine-D2 receptor
Eur. J. Pharmac.
(1991)
Schwann-cell myelination in a chemically defined medium-demonstration of a requirement for additives that promote schwann-cell extracellular-matrix formation
Dev. Brain Res.
(1987)
Interactions between glutamatergic and monoaminergic systems within the basal ganglia: implications for schizophrenia and Parkinson's disease
Trends Neurosci.
(1990)
Interfering with glutamatergic neurotransmission by means of NMDA antagonist administration discloses the locomotor stimulatory potential of other transmitter systems
Pharmac. Biochem. Behav.
(1990)
Topographic distribution of possible glutamatergic pathways from the frontal cortex to the striatum and substantia nigra in rats
Neuropharmacology
(1982)
Ascorbate injury and EDTA (or manganese) protection of D-2 dopamine receptors
Eur. J. Pharmac.
(1982)
Presynaptic regulation of neurotransmitter release in the brain: facts and hypothesis
Neuroscience
(1984)
Ascorbic acid levels in mammalian tissues and its metabolic significance
Comp. Biochem. Physiol.
(1972)
Interactions between dopamine and amino acid-induced excitation and inhibition in the striatum
Brain Res.
(1986)
Glutamate neurotoxicity and diseases of the nervous system
Neuron
(1988)
Molecular biology of the dopamine receptors
Eur. J. Pharmac.
(1991)
Changes in brain chemistry produced by dopaminergic agents: in vivo electrochemical monitoring reveals opposite changes in anesthetized vs unanesthetized rats
Brain Res.
(1983)
Brain dialysis in conscious rats confirms in vivo electrochemical evidence that dopaminergic stimulation releases ascorbate
Life Sci.
(1984)
Presynaptic kainate and receptors regulate excitatory amino acid release in the olfactory cortex
Brain Res.
(1983)
Two syndromes in schizophrenia?
Trends Neurosci.
(1982)
Brain dopamine and behaviour: a critical analysis of the relationship between dopamine antagonism and therapeutic efficacy of neuroleptic drugs
J. Psychiat. Res.
(1974)
Neurochemical and behavioural changes induced by ascorbic acid and d-amphetamine in the rat
Pharmac. Res. Commun.
(1987)
Effects of cortical ablation on apomorphine-induced and scopolamine-induced changes in dopamine turnover and ascorbic acid catabolism in the rat striatum
Eur. J. Pharmac.
(1992)
The effects of cortical ablation on d- a phetamine-induced changes in striatal dopamine turnover and ascorbic acid catabolism in the rat
Neurosci. Lett.
(1992)
Mechanism of dopamine-β-hydroxylation
J. biol. Chem.
(1981)
Potentiation of haloperidol-induced catalepsy by ascorbic acid in rats and nonhuman primates
Pharmac. Biochem. Behav.
(1986)
The physiology and pharmacology of mammalian basal ganglia
Prog. Neurobiol.
(1980)
D-2 dopamine autoreceptor selective drugs: do they really exist?
Life Sci.
(1990)
In vivo voltammetry with electrodes that discriminate between dopamine and ascorbate
Brain Res.
(1982)
Simultaneous electrochemical and unit recording measurements: characterization of the effects of d-amphetamine and ascorbic acid on neostriatal neurons
Brain Res.
(1983)
Ascorbic acid protects lipids in human plasma and low-density lipoprotein against oxidative damage
Am. J. Clin. Nutr.
(1991)
The effect of age, growth retardation and asphyxia on ascorbic acid concentrations in developing brain
J. Neurochem.
(1973)
Oxidants, antioxidants, and the degenerative diseases of aging
Guanyl nucleotide interactions with dopaminergic binding sites labeled by [3H]Spiroperidol in human caudate and putamen: guanyl nucleotides enhance ascorbate-induced lipid peroxidation and cause an apparent loss of high affinity binding sites
Molec. Pharmac.
(1988)
Schizophrenia—the characteristic symptoms
Schiz. Bull.
(1991)
The effect of amphetamine and caffeine on neuronal activity in the neocortex of the cat
Neuropharmacology
(1978)
Neurotransmission in the brain by diffusion through the extracellular fluid
Neuro Report
(1993)
Cited by (320)
Reply for Comment on: Vitamin C and catheter-related bladder discomfort after transurethral resection of bladder tumor
2024, Journal of Clinical AnesthesiaImpact of micronutrients and nutraceuticals on cognitive function and performance in Alzheimer's disease
2024, Ageing Research ReviewsAscorbate and its transporter SVCT2: The dynamic duo's integrated roles in CNS neurobiology and pathophysiology
2024, Free Radical Biology and MedicineConstruction of a Brain-specific SLC23A2 Gene Knockout Mice Model
2023, Neuroscience
Copyright © 1994 Published by Elsevier Ltd.